Julie Gralow: Webinar on the current US IV Fluid Shortage by NCODA
Julie Gralow, Chief Medical Officer of ASCO, shared a post on LinkedIn by NCODA, adding:
“Join us on Tuesday for this webinar on the current US IV Fluid Shortage hosted by NCODA.”
Quoting NCODA’s post:
“The ongoing IV fluid shortage poses serious challenges for oncology care, impacting treatment protocols and patient outcomes. On Tuesday, October 29, at 2 pm EST, join top healthcare leaders for an in-depth discussion on navigating these supply chain issues and adopting strategies to sustain care.
Explore root causes, evidence-based conservation tactics, and practical approaches for future preparedness.
Panel includes:
Moderator:
- Abdelghany, Osama, PharmD, MHA, BCOP | Executive Director of Oncology Pharmacy Services | Yale New Haven Health
Panelists:
- Michael Ganio, PharmD, MS, BCPS | Senior Director of Pharmacy Practice & Quality | ASHP
- James Gilmore, PharmD | Chief Pharmacy and Procurement Officer | American Oncology Network
- Julie Gralow, MD | Chief Medical Officer | American Society of Clinical Oncology (ASCO)
- Charles Hartenstine | Vice President of Strategic Global Sourcing | Cencora
Open to members and non-members. To receive a calendar invite, email [email protected], or join via the link.”
More posts featuring Julie Gralow.
Julie Gralow is the Chief Medical Officer (CMO) of the American Society of Clinical Oncology (ASCO). She is the founder of the Women’s Empowerment Cancer Advocacy Network (WE CAN).
Previously, she was the Jill Bennett Endowed Professor of Breast Cancer at the University of Washington School of Medicine, Professor in the Clinical Research Division of the Fred Hutchinson Cancer Research Center, as well as Director of Breast Medical Oncology at the Seattle Cancer Care Alliance.
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023